China Universal Asset Management »

Ovid Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $16k 14k 1.18
2024-06-30 $6.4k 8.3k 0.77
2024-03-31 $41k 14k 3.05
2023-12-31 $26k 8.2k 3.22
2022-09-30 $1.0k 660 1.52

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Ovid Therapeutics

Rubric Capital Management
BlackRock
BlackRock
BVF
Vanguard Group
Siren
Acadian Asset Management
Kennedy Capital Management
Jpmorgan Chase & Co
Driehaus Capital Management
State Street Corporation
Geode Capital Management
TLS Advisors
Wells Fargo & Company
Northern Trust

View all funds holding Ovid Therapeutics